Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ETD-001 Gel for Hypertrophic Scars
NCT07891416Phase 2Not yet recruiting
- Sponsor
- ETERN Therapeutics
- Start
- Feb 2027
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
A Phase 2 trial of ETD-001 in Hypertrophic Scar (HS), sponsored by ETERN Therapeutics. Planned start Feb 2027; status: not yet recruiting.
02
Drugs
ETD-001
03
Conditions
Hypertrophic Scar (HS)
Beyond the preview
Go deeper on NCT07891416.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07891416.